A federal jury in Chicago on Monday found AbbVie Inc. fraudulently misrepresented the risks of its testosterone replacement drug AndroGel and ordered the drugmaker to pay $150 million in punitive damages. The verdict, which came in response to a lawsuit …
from News – Insurance Journal
没有评论:
发表评论